Your session is about to expire
← Back to Search
CAP-1002 for Duchenne Muscular Dystrophy (HOPE-2-OLE Trial)
HOPE-2-OLE Trial Summary
This trial will provide CAP-1002 to subjects who completed the HOPE-2 trial and will explore the safety and efficacy of eight intravenous administrations of CAP-1002, each separated by three months.
HOPE-2-OLE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HOPE-2-OLE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing and able to agree to participate in the trial, and if under 18, I have parental or guardian consent.I have a chronic lung condition not related to muscular dystrophy.I am willing and able to follow the trial's requirements.I have not had a respiratory illness in the last 60 days.I am likely to have major surgery within a year after starting treatment.
- Group 1: Open-label arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has this therapy been federally sanctioned?
"While there is some data backing the safety of this treatment, it receives a score of 2 because, as a Phase 2 trial, there is no evidence yet of its efficacy."
Is this research still looking for participants?
"Unfortunately, this particular trial is not presently looking for new patients. The posting dates on clinicaltrials.gov show that recruitment began on July 20th 2020 and stopped on February 1st 2022. Although this study has completed recruitment, there are many other opportunities available as there are 91 other studies currently searching for participants."
How many people are eligible for this research project?
"Unfortunately, this trial is not currently looking for new patients. It was last updated on February 1st, 2022 and originally posted on July 20th, 2020. However, if you are seeking other trials, 88 studies for Becker muscular dystrophy are actively recruiting and 3 have open enrollment for this treatment specifically."
In how many different medical facilities is this research being conducted?
"The trial locations include University of California, Davis in Sacramento, Children's Hospital Colorado in Aurora, Washington University in Saint Louis, Missouri as well other 5 additional sites."
Is this a common line of treatment?
"Currently, there are 3 ongoing studies for this treatment. One of these trials is in Phase 3. The majority of the research centres conducting these studies are located in Los Angeles, but there are a total of 14 locations across the United States."
Who else is applying?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger